img

Global Drug based on CAR T-Cell Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Drug based on CAR T-Cell Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
Drug based on CAR T-Cell report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Drug based on CAR T-Cell market is projected to reach US$ 583.8 million in 2029, increasing from US$ 366 million in 2022, with the CAGR of 7.0% during the period of 2024 to 2029. Demand from Lymphoma and Multiple Myeloma are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Drug based on CAR T-Cell market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Segment by Type
CD19-targeted
BCMA-targeted

Segment by Application


Lymphoma
Multiple Myeloma
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Drug based on CAR T-Cell market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Drug based on CAR T-Cell introduction, etc. Drug based on CAR T-Cell Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Drug based on CAR T-Cell market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Drug based on CAR T-Cell
1.1 Drug based on CAR T-Cell Market Overview
1.1.1 Drug based on CAR T-Cell Product Scope
1.1.2 Drug based on CAR T-Cell Market Status and Outlook
1.2 Global Drug based on CAR T-Cell Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Drug based on CAR T-Cell Market Size by Region (2018-2029)
1.4 Global Drug based on CAR T-Cell Historic Market Size by Region (2018-2024)
1.5 Global Drug based on CAR T-Cell Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Drug based on CAR T-Cell Market Size (2018-2029)
1.6.1 North America Drug based on CAR T-Cell Market Size (2018-2029)
1.6.2 Europe Drug based on CAR T-Cell Market Size (2018-2029)
1.6.3 Asia-Pacific Drug based on CAR T-Cell Market Size (2018-2029)
1.6.4 Latin America Drug based on CAR T-Cell Market Size (2018-2029)
1.6.5 Middle East & Africa Drug based on CAR T-Cell Market Size (2018-2029)
2 Drug based on CAR T-Cell Market by Type
2.1 Introduction
2.1.1 CD19-targeted
2.1.2 BCMA-targeted
2.2 Global Drug based on CAR T-Cell Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Drug based on CAR T-Cell Historic Market Size by Type (2018-2024)
2.2.2 Global Drug based on CAR T-Cell Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Drug based on CAR T-Cell Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Drug based on CAR T-Cell Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Drug based on CAR T-Cell Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Drug based on CAR T-Cell Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Drug based on CAR T-Cell Revenue Breakdown by Type (2018-2029)
3 Drug based on CAR T-Cell Market Overview by Application
3.1 Introduction
3.1.1 Lymphoma
3.1.2 Multiple Myeloma
3.2 Global Drug based on CAR T-Cell Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Drug based on CAR T-Cell Historic Market Size by Application (2018-2024)
3.2.2 Global Drug based on CAR T-Cell Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Drug based on CAR T-Cell Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Drug based on CAR T-Cell Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Drug based on CAR T-Cell Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Drug based on CAR T-Cell Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Drug based on CAR T-Cell Revenue Breakdown by Application (2018-2029)
4 Drug based on CAR T-Cell Competition Analysis by Players
4.1 Global Drug based on CAR T-Cell Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug based on CAR T-Cell as of 2022)
4.3 Date of Key Players Enter into Drug based on CAR T-Cell Market
4.4 Global Top Players Drug based on CAR T-Cell Headquarters and Area Served
4.5 Key Players Drug based on CAR T-Cell Product Solution and Service
4.6 Competitive Status
4.6.1 Drug based on CAR T-Cell Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novartis
5.1.1 Novartis Profile
5.1.2 Novartis Main Business
5.1.3 Novartis Drug based on CAR T-Cell Products, Services and Solutions
5.1.4 Novartis Drug based on CAR T-Cell Revenue (US$ Million) & (2018-2024)
5.1.5 Novartis Recent Developments
5.2 Gilead Sciences
5.2.1 Gilead Sciences Profile
5.2.2 Gilead Sciences Main Business
5.2.3 Gilead Sciences Drug based on CAR T-Cell Products, Services and Solutions
5.2.4 Gilead Sciences Drug based on CAR T-Cell Revenue (US$ Million) & (2018-2024)
5.2.5 Gilead Sciences Recent Developments
5.3 Bristol-Myers Squibb
5.3.1 Bristol-Myers Squibb Profile
5.3.2 Bristol-Myers Squibb Main Business
5.3.3 Bristol-Myers Squibb Drug based on CAR T-Cell Products, Services and Solutions
5.3.4 Bristol-Myers Squibb Drug based on CAR T-Cell Revenue (US$ Million) & (2018-2024)
5.3.5 J & J Recent Developments
5.4 J & J
5.4.1 J & J Profile
5.4.2 J & J Main Business
5.4.3 J & J Drug based on CAR T-Cell Products, Services and Solutions
5.4.4 J & J Drug based on CAR T-Cell Revenue (US$ Million) & (2018-2024)
5.4.5 J & J Recent Developments
5.5 JW Therapeutics
5.5.1 JW Therapeutics Profile
5.5.2 JW Therapeutics Main Business
5.5.3 JW Therapeutics Drug based on CAR T-Cell Products, Services and Solutions
5.5.4 JW Therapeutics Drug based on CAR T-Cell Revenue (US$ Million) & (2018-2024)
5.5.5 JW Therapeutics Recent Developments
5.6 FOSUNKite
5.6.1 FOSUNKite Profile
5.6.2 FOSUNKite Main Business
5.6.3 FOSUNKite Drug based on CAR T-Cell Products, Services and Solutions
5.6.4 FOSUNKite Drug based on CAR T-Cell Revenue (US$ Million) & (2018-2024)
5.6.5 FOSUNKite Recent Developments
5.7 CARsgen Therapeutics (Pipeline)
5.7.1 CARsgen Therapeutics (Pipeline) Profile
5.7.2 CARsgen Therapeutics (Pipeline) Main Business
5.7.3 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Products, Services and Solutions
5.7.4 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Revenue (US$ Million) & (2018-2024)
5.7.5 CARsgen Therapeutics (Pipeline) Recent Developments
5.8 CARsgen Therapeutics
5.8.1 CARsgen Therapeutics Profile
5.8.2 CARsgen Therapeutics Main Business
5.8.3 CARsgen Therapeutics Drug based on CAR T-Cell Products, Services and Solutions
5.8.4 CARsgen Therapeutics Drug based on CAR T-Cell Revenue (US$ Million) & (2018-2024)
5.8.5 CARsgen Therapeutics Recent Developments
5.9 Autolus Therapeutics
5.9.1 Autolus Therapeutics Profile
5.9.2 Autolus Therapeutics Main Business
5.9.3 Autolus Therapeutics Drug based on CAR T-Cell Products, Services and Solutions
5.9.4 Autolus Therapeutics Drug based on CAR T-Cell Revenue (US$ Million) & (2018-2024)
5.9.5 Autolus Therapeutics Recent Developments
5.10 Sorrento Therapeutics
5.10.1 Sorrento Therapeutics Profile
5.10.2 Sorrento Therapeutics Main Business
5.10.3 Sorrento Therapeutics Drug based on CAR T-Cell Products, Services and Solutions
5.10.4 Sorrento Therapeutics Drug based on CAR T-Cell Revenue (US$ Million) & (2018-2024)
5.10.5 Sorrento Therapeutics Recent Developments
5.11 Mustang Bio
5.11.1 Mustang Bio Profile
5.11.2 Mustang Bio Main Business
5.11.3 Mustang Bio Drug based on CAR T-Cell Products, Services and Solutions
5.11.4 Mustang Bio Drug based on CAR T-Cell Revenue (US$ Million) & (2018-2024)
5.11.5 Mustang Bio Recent Developments
5.12 Bluebird Bio
5.12.1 Bluebird Bio Profile
5.12.2 Bluebird Bio Main Business
5.12.3 Bluebird Bio Drug based on CAR T-Cell Products, Services and Solutions
5.12.4 Bluebird Bio Drug based on CAR T-Cell Revenue (US$ Million) & (2018-2024)
5.12.5 Bluebird Bio Recent Developments
5.13 Cellectis
5.13.1 Cellectis Profile
5.13.2 Cellectis Main Business
5.13.3 Cellectis Drug based on CAR T-Cell Products, Services and Solutions
5.13.4 Cellectis Drug based on CAR T-Cell Revenue (US$ Million) & (2018-2024)
5.13.5 Cellectis Recent Developments
5.14 Allogene Therapeutics
5.14.1 Allogene Therapeutics Profile
5.14.2 Allogene Therapeutics Main Business
5.14.3 Allogene Therapeutics Drug based on CAR T-Cell Products, Services and Solutions
5.14.4 Allogene Therapeutics Drug based on CAR T-Cell Revenue (US$ Million) & (2018-2024)
5.14.5 Allogene Therapeutics Recent Developments
5.15 Celyad
5.15.1 Celyad Profile
5.15.2 Celyad Main Business
5.15.3 Celyad Drug based on CAR T-Cell Products, Services and Solutions
5.15.4 Celyad Drug based on CAR T-Cell Revenue (US$ Million) & (2018-2024)
5.15.5 Celyad Recent Developments
6 North America
6.1 North America Drug based on CAR T-Cell Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Drug based on CAR T-Cell Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Drug based on CAR T-Cell Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Drug based on CAR T-Cell Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Drug based on CAR T-Cell Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Drug based on CAR T-Cell Market Dynamics
11.1 Drug based on CAR T-Cell Industry Trends
11.2 Drug based on CAR T-Cell Market Drivers
11.3 Drug based on CAR T-Cell Market Challenges
11.4 Drug based on CAR T-Cell Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Drug based on CAR T-Cell Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Drug based on CAR T-Cell Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Drug based on CAR T-Cell Market Size Share by Region (2018-2024)
Table 4. Global Drug based on CAR T-Cell Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Drug based on CAR T-Cell Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Drug based on CAR T-Cell Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Drug based on CAR T-Cell Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Drug based on CAR T-Cell Revenue Market Share by Type (2018-2024)
Table 9. Global Drug based on CAR T-Cell Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Drug based on CAR T-Cell Revenue Market Share by Type (2024-2029)
Table 11. North America Drug based on CAR T-Cell Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Drug based on CAR T-Cell Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Drug based on CAR T-Cell Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Drug based on CAR T-Cell Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Drug based on CAR T-Cell Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Drug based on CAR T-Cell Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Drug based on CAR T-Cell Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Drug based on CAR T-Cell Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Drug based on CAR T-Cell Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Drug based on CAR T-Cell Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Drug based on CAR T-Cell Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Drug based on CAR T-Cell Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Drug based on CAR T-Cell Revenue Market Share by Application (2018-2024)
Table 24. Global Drug based on CAR T-Cell Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Drug based on CAR T-Cell Revenue Market Share by Application (2024-2029)
Table 26. North America Drug based on CAR T-Cell Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Drug based on CAR T-Cell Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Drug based on CAR T-Cell Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Drug based on CAR T-Cell Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Drug based on CAR T-Cell Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Drug based on CAR T-Cell Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Drug based on CAR T-Cell Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Drug based on CAR T-Cell Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Drug based on CAR T-Cell Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Drug based on CAR T-Cell Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Drug based on CAR T-Cell Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Drug based on CAR T-Cell Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug based on CAR T-Cell as of 2022)
Table 39. Date of Key Players Enter into Drug based on CAR T-Cell Market
Table 40. Global Drug based on CAR T-Cell Key Players Headquarters and Area Served
Table 41. Drug based on CAR T-Cell Product Solution and Service
Table 42. Global Drug based on CAR T-Cell Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Novartis Basic Information List
Table 45. Novartis Description and Business Overview
Table 46. Novartis Drug based on CAR T-Cell Products, Services and Solutions
Table 47. Revenue (US$ Million) in Drug based on CAR T-Cell Business of Novartis (2018-2024)
Table 48. Novartis Recent Developments
Table 49. Gilead Sciences Basic Information List
Table 50. Gilead Sciences Description and Business Overview
Table 51. Gilead Sciences Drug based on CAR T-Cell Products, Services and Solutions
Table 52. Revenue (US$ Million) in Drug based on CAR T-Cell Business of Gilead Sciences (2018-2024)
Table 53. Gilead Sciences Recent Developments
Table 54. Bristol-Myers Squibb Basic Information List
Table 55. Bristol-Myers Squibb Description and Business Overview
Table 56. Bristol-Myers Squibb Drug based on CAR T-Cell Products, Services and Solutions
Table 57. Revenue (US$ Million) in Drug based on CAR T-Cell Business of Bristol-Myers Squibb (2018-2024)
Table 58. Bristol-Myers Squibb Recent Developments
Table 59. J & J Basic Information List
Table 60. J & J Description and Business Overview
Table 61. J & J Drug based on CAR T-Cell Products, Services and Solutions
Table 62. Revenue (US$ Million) in Drug based on CAR T-Cell Business of J & J (2018-2024)
Table 63. J & J Recent Developments
Table 64. JW Therapeutics Basic Information List
Table 65. JW Therapeutics Description and Business Overview
Table 66. JW Therapeutics Drug based on CAR T-Cell Products, Services and Solutions
Table 67. Revenue (US$ Million) in Drug based on CAR T-Cell Business of JW Therapeutics (2018-2024)
Table 68. JW Therapeutics Recent Developments
Table 69. FOSUNKite Basic Information List
Table 70. FOSUNKite Description and Business Overview
Table 71. FOSUNKite Drug based on CAR T-Cell Products, Services and Solutions
Table 72. Revenue (US$ Million) in Drug based on CAR T-Cell Business of FOSUNKite (2018-2024)
Table 73. FOSUNKite Recent Developments
Table 74. CARsgen Therapeutics (Pipeline) Basic Information List
Table 75. CARsgen Therapeutics (Pipeline) Description and Business Overview
Table 76. CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Products, Services and Solutions
Table 77. Revenue (US$ Million) in Drug based on CAR T-Cell Business of CARsgen Therapeutics (Pipeline) (2018-2024)
Table 78. CARsgen Therapeutics (Pipeline) Recent Developments
Table 79. CARsgen Therapeutics Basic Information List
Table 80. CARsgen Therapeutics Description and Business Overview
Table 81. CARsgen Therapeutics Drug based on CAR T-Cell Products, Services and Solutions
Table 82. Revenue (US$ Million) in Drug based on CAR T-Cell Business of CARsgen Therapeutics (2018-2024)
Table 83. CARsgen Therapeutics Recent Developments
Table 84. Autolus Therapeutics Basic Information List
Table 85. Autolus Therapeutics Description and Business Overview
Table 86. Autolus Therapeutics Drug based on CAR T-Cell Products, Services and Solutions
Table 87. Revenue (US$ Million) in Drug based on CAR T-Cell Business of Autolus Therapeutics (2018-2024)
Table 88. Autolus Therapeutics Recent Developments
Table 89. Sorrento Therapeutics Basic Information List
Table 90. Sorrento Therapeutics Description and Business Overview
Table 91. Sorrento Therapeutics Drug based on CAR T-Cell Products, Services and Solutions
Table 92. Revenue (US$ Million) in Drug based on CAR T-Cell Business of Sorrento Therapeutics (2018-2024)
Table 93. Sorrento Therapeutics Recent Developments
Table 94. Mustang Bio Basic Information List
Table 95. Mustang Bio Description and Business Overview
Table 96. Mustang Bio Drug based on CAR T-Cell Products, Services and Solutions
Table 97. Revenue (US$ Million) in Drug based on CAR T-Cell Business of Mustang Bio (2018-2024)
Table 98. Mustang Bio Recent Developments
Table 99. Bluebird Bio Basic Information List
Table 100. Bluebird Bio Description and Business Overview
Table 101. Bluebird Bio Drug based on CAR T-Cell Products, Services and Solutions
Table 102. Revenue (US$ Million) in Drug based on CAR T-Cell Business of Bluebird Bio (2018-2024)
Table 103. Bluebird Bio Recent Developments
Table 104. Cellectis Basic Information List
Table 105. Cellectis Description and Business Overview
Table 106. Cellectis Drug based on CAR T-Cell Products, Services and Solutions
Table 107. Revenue (US$ Million) in Drug based on CAR T-Cell Business of Cellectis (2018-2024)
Table 108. Cellectis Recent Developments
Table 109. Allogene Therapeutics Basic Information List
Table 110. Allogene Therapeutics Description and Business Overview
Table 111. Allogene Therapeutics Drug based on CAR T-Cell Products, Services and Solutions
Table 112. Revenue (US$ Million) in Drug based on CAR T-Cell Business of Allogene Therapeutics (2018-2024)
Table 113. Allogene Therapeutics Recent Developments
Table 114. Celyad Basic Information List
Table 115. Celyad Description and Business Overview
Table 116. Celyad Drug based on CAR T-Cell Products, Services and Solutions
Table 117. Revenue (US$ Million) in Drug based on CAR T-Cell Business of Celyad (2018-2024)
Table 118. Celyad Recent Developments
Table 119. North America Drug based on CAR T-Cell Market Size by Country (2018-2024) & (US$ Million)
Table 120. North America Drug based on CAR T-Cell Market Size by Country (2024-2029) & (US$ Million)
Table 121. Europe Drug based on CAR T-Cell Market Size by Country (2018-2024) & (US$ Million)
Table 122. Europe Drug based on CAR T-Cell Market Size by Country (2024-2029) & (US$ Million)
Table 123. Asia-Pacific Drug based on CAR T-Cell Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 124. Asia-Pacific Drug based on CAR T-Cell Market Size by Region (2018-2024) & (US$ Million)
Table 125. Asia-Pacific Drug based on CAR T-Cell Market Size by Region (2024-2029) & (US$ Million)
Table 126. Asia-Pacific Drug based on CAR T-Cell Market Share by Region (2018-2024)
Table 127. Asia-Pacific Drug based on CAR T-Cell Market Share by Region (2024-2029)
Table 128. Latin America Drug based on CAR T-Cell Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 129. Latin America Drug based on CAR T-Cell Market Size by Country (2018-2024) & (US$ Million)
Table 130. Latin America Drug based on CAR T-Cell Market Size by Country (2024-2029) & (US$ Million)
Table 131. Middle East & Africa Drug based on CAR T-Cell Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 132. Middle East & Africa Drug based on CAR T-Cell Market Size by Country (2018-2024) & (US$ Million)
Table 133. Middle East & Africa Drug based on CAR T-Cell Market Size by Country (2024-2029) & (US$ Million)
Table 134. Drug based on CAR T-Cell Market Trends
Table 135. Drug based on CAR T-Cell Market Drivers
Table 136. Drug based on CAR T-Cell Market Challenges
Table 137. Drug based on CAR T-Cell Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug based on CAR T-Cell Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Drug based on CAR T-Cell Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Drug based on CAR T-Cell Market Share by Regions: 2022 VS 2029
Figure 4. Global Drug based on CAR T-Cell Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Drug based on CAR T-Cell Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Drug based on CAR T-Cell Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Drug based on CAR T-Cell Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Drug based on CAR T-Cell Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Drug based on CAR T-Cell Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of CD19-targeted
Figure 11. Global CD19-targeted Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of BCMA-targeted
Figure 13. Global BCMA-targeted Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Global Drug based on CAR T-Cell Market Size Share by Type: 2022 & 2029
Figure 15. North America Drug based on CAR T-Cell Revenue Market Share by Type (2018-2029)
Figure 16. Europe Drug based on CAR T-Cell Revenue Market Share by Type (2018-2029)
Figure 17. Asia-Pacific Drug based on CAR T-Cell Revenue Market Share by Type (2018-2029)
Figure 18. Latin America Drug based on CAR T-Cell Revenue Market Share by Type (2018-2029)
Figure 19. Middle East and Africa Drug based on CAR T-Cell Revenue Market Share by Type (2018-2029)
Figure 20. Lymphoma Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 21. Multiple Myeloma Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Global Drug based on CAR T-Cell Market Size Share by Application: 2022 & 2029
Figure 23. North America Drug based on CAR T-Cell Revenue Market Share by Application (2018-2029)
Figure 24. Europe Drug based on CAR T-Cell Revenue Market Share by Application (2018-2029)
Figure 25. Asia-Pacific Drug based on CAR T-Cell Revenue Market Share by Application (2018-2029)
Figure 26. Latin America Drug based on CAR T-Cell Revenue Market Share by Application (2018-2029)
Figure 27. Middle East and Africa Drug based on CAR T-Cell Revenue Market Share by Application (2018-2029)
Figure 28. Drug based on CAR T-Cell Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 29. Global Top 5 and Top 10 Players Drug based on CAR T-Cell Market Share in 2022
Figure 30. North America Drug based on CAR T-Cell Market Share by Country (2018-2029)
Figure 31. United States Drug based on CAR T-Cell Market Size (2018-2029) & (US$ Million)
Figure 32. Canada Drug based on CAR T-Cell Market Size (2018-2029) & (US$ Million)
Figure 33. Germany Drug based on CAR T-Cell Market Size (2018-2029) & (US$ Million)
Figure 34. France Drug based on CAR T-Cell Market Size (2018-2029) & (US$ Million)
Figure 35. U.K. Drug based on CAR T-Cell Market Size (2018-2029) & (US$ Million)
Figure 36. Italy Drug based on CAR T-Cell Market Size (2018-2029) & (US$ Million)
Figure 37. Russia Drug based on CAR T-Cell Market Size (2018-2029) & (US$ Million)
Figure 38. Nordic Countries Drug based on CAR T-Cell Market Size (2018-2029) & (US$ Million)
Figure 39. Asia-Pacific Drug based on CAR T-Cell Market Share by Region (2018-2029)
Figure 40. China Drug based on CAR T-Cell Market Size (2018-2029) & (US$ Million)
Figure 41. Japan Drug based on CAR T-Cell Market Size (2018-2029) & (US$ Million)
Figure 42. South Korea Drug based on CAR T-Cell Market Size (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Drug based on CAR T-Cell Market Size (2018-2029) & (US$ Million)
Figure 44. India Drug based on CAR T-Cell Market Size (2018-2029) & (US$ Million)
Figure 45. Australia Drug based on CAR T-Cell Market Size (2018-2029) & (US$ Million)
Figure 46. Latin America Drug based on CAR T-Cell Market Share by Country (2018-2029)
Figure 47. Mexico Drug based on CAR T-Cell Market Size (2018-2029) & (US$ Million)
Figure 48. Brazil Drug based on CAR T-Cell Market Size (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Drug based on CAR T-Cell Market Share by Country (2018-2029)
Figure 50. Turkey Drug based on CAR T-Cell Market Size (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Drug based on CAR T-Cell Market Size (2018-2029) & (US$ Million)
Figure 52. UAE Drug based on CAR T-Cell Market Size (2018-2029) & (US$ Million)
Figure 53. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries